Oncol Rep 41: [Related article:] 2453–2463, 2019; DOI:
10.3892/or.2019.7016
Following the publication of the above article and a
corrigendum that was published to address issues of duplicated data
panels in Fig. 4 (doi: 10.3892/or.2023.8484), a concerned reader
has drawn to the Editor's attention that Fig. 3B also contains a
matching pair of identical flow cytometry scatterplots where the
results from different experiments were intended to have been
portrayed, and certain of the western blotting data shown in Fig.
3C are strikingly similar to data that had appeared in Figs. 2 and
3 in a previously published paper written by different authors at
different research institutes [Tian F, Ding D and Li D:
Fangchinoline targets PI3K and suppresses PI3K/AKT signaling
pathway in SGC7901 cells. Int J Oncol 46: 2355-2363, 2015].
In view of the fact that certain of the data in the
above article had already appeared in a previously published paper,
and given the large number of apparently overlapping data panels
identified in several of the figures, the Editor of Oncology
Reports has decided that this paper should be retracted from
the publication. After having been in contact with the authors,
they accepted the decision to retract the paper. The Editor
apologizes to the readership for any inconvenience caused.
